Myopia (short sighted) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Condition: Myopia Interventions: Device: CP1; Drug: 0.01% atropine Sponsors: Kubota Vision Inc.; China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
Condition: Myopia Interventions: Drug: 0.01% atropine; Other: 0.9% sodium chloride Sponsor: He Eye Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Conditions: Myopia; Juvenile Myopia; Myopia Progression Interventions: Device: Single vision, impact-resistant spectacle lenses; Test Arm; Device: Single vision, impact-resistant spectacle lenses; Control Arm Sponsor: SightGlass Vision, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Condition: Myopia Interventions: Device: CP1; Drug: 0.01% atropine Sponsors: Kubota Vision Inc.; China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
Condition: Myopia Interventions: Drug: 0.01% atropine; Other: 0.9% sodium chloride Sponsor: He Eye Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Conditions: Myopia; Juvenile Myopia; Myopia Progression Interventions: Device: Single vision, impact-resistant spectacle lenses; Test Arm; Device: Single vision, impact-resistant spectacle lenses; Control Arm Sponsor: SightGlass Vision, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Condition: Myopia Interventions: Device: CP1; Drug: 0.01% atropine Sponsors: Kubota Vision Inc.; China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
Condition: Myopia Interventions: Drug: 0.01% atropine; Other: 0.9% sodium chloride Sponsor: He Eye Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Conditions: Myopia; Juvenile Myopia; Myopia Progression Interventions: Device: Single vision, impact-resistant spectacle lenses; Test Arm; Device: Single vision, impact-resistant spectacle lenses; Control Arm Sponsor: SightGlass Vision, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Condition: Myopia Interventions: Device: CP1; Drug: 0.01% atropine Sponsors: Kubota Vision Inc.; China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
Condition: Myopia Interventions: Drug: 0.01% atropine; Other: 0.9% sodium chloride Sponsor: He Eye Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Conditions: Myopia; Juvenile Myopia; Myopia Progression Interventions: Device: Single vision, impact-resistant spectacle lenses; Test Arm; Device: Single vision, impact-resistant spectacle lenses; Control Arm Sponsor: SightGlass Vision, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Condition: Myopia Interventions: Device: CP1; Drug: 0.01% atropine Sponsors: Kubota Vision Inc.; China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
Condition: Myopia Interventions: Drug: 0.01% atropine; Other: 0.9% sodium chloride Sponsor: He Eye Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Conditions: Myopia; Juvenile Myopia; Myopia Progression Interventions: Device: Single vision, impact-resistant spectacle lenses; Test Arm; Device: Single vision, impact-resistant spectacle lenses; Control Arm Sponsor: SightGlass Vision, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials